[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:nonalcoholic-steatohepatitis":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":312,"states":313},"Nonalcoholic Steatohepatitis",54,41,[8,16,23,30,36,42,48,54,60,66,73,79,85,91,97,103,109,115,121,127,133,139,146,152,158,163,169,175,181,187,193,199,205,210,216,222,227,233,239,245,251,257,264,270,276,281,287,294,300,306],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05519475","A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition",[12],"Phase 2","RECRUITING","2026-08-26T02:19:23.493898Z","2026-07-05T05:32:16.802708Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06215716","A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)\u002FMetabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis",[20],"Phase 3","2026-08-26T02:17:36.611194Z","2026-07-05T05:32:16.745637Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT07553663","Evaluating the Pharmacokinetics and Safety of Miricorilant",[27],"Phase 1","2026-08-26T02:18:51.833592Z","2026-05-29T15:36:40.191799Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":34,"content_modified":35},"NCT06588699","Digoxin In NASH (CODIN)",[12],"2026-08-26T02:16:23.080181Z","2026-05-05T02:43:29.734574Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT04987879","NASH AMPK Exercise Dosing (AMPED) Trial",[],"2026-08-03T01:56:45.025842Z","2026-05-05T02:43:29.723485Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06528314","A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH\u002FMASH",[20],"2026-08-26T02:15:15.642947Z","2026-05-05T02:43:29.476317Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT04833140","Estrogen Administration for the Treatment of NASH in Postmenopausal Women",[20],"2026-08-03T02:30:20.344839Z","2026-05-05T02:43:29.469262Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT07221188","A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH",[20],"2026-08-26T02:15:25.633039Z","2026-05-05T02:43:29.350788Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT06920043","A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH",[12],"2026-08-26T02:18:30.351130Z","2026-05-05T02:43:28.874655Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":71,"content_modified":72},"NCT06836609","A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD\u002FMASH)",[70],"Phase 1\u002FPhase 2","2026-08-26T02:18:31.164304Z","2026-05-05T02:43:28.738012Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT07221227","A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH",[20],"2026-08-26T02:17:09.131534Z","2026-05-05T02:43:27.421459Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT06419374","A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH",[20],"2026-08-26T02:19:03.581490Z","2026-05-05T02:43:27.326108Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT07288138","A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)",[12],"2026-08-26T02:16:24.970704Z","2026-05-05T02:43:27.173275Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT06318169","A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)",[20],"2026-08-26T02:17:53.433613Z","2026-05-05T02:43:26.906858Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT07491458","A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)",[12],"2026-08-26T02:19:14.560989Z","2026-05-05T02:43:26.740214Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":107,"content_modified":108},"NCT04501406","Low-Dose Pioglitazone in Patients With NASH (AIM 2)",[12],"2026-08-26T02:16:52.995882Z","2026-05-05T02:35:31.913547Z",{"nct_id":110,"title":111,"phases":112,"status":13,"updated_at":113,"content_modified":114},"NCT03587831","Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis",[],"2026-08-26T02:17:12.307088Z","2026-05-05T02:35:31.766812Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":119,"content_modified":120},"NCT06138821","Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial",[],"2026-08-26T02:16:29.226604Z","2026-07-05T05:32:16.744670Z",{"nct_id":122,"title":123,"phases":124,"status":13,"updated_at":125,"content_modified":126},"NCT07335601","Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH",[12],"2026-08-26T02:18:58.958025Z","2026-07-05T05:32:16.677970Z",{"nct_id":128,"title":129,"phases":130,"status":13,"updated_at":131,"content_modified":132},"NCT07527910","A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD",[12],"2026-08-26T02:19:05.360997Z","2026-07-05T03:45:20.252831Z",{"nct_id":134,"title":135,"phases":136,"status":13,"updated_at":137,"content_modified":138},"NCT05526144","Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans",[12],"2026-08-26T02:16:45.157238Z","2026-05-05T02:43:29.659734Z",{"nct_id":140,"title":141,"phases":142,"status":13,"updated_at":144,"content_modified":145},"NCT06374875","Fibrosis Lessens After Metabolic Surgery",[143],"Phase 4","2026-08-26T02:16:46.147215Z","2026-05-05T02:43:29.501896Z",{"nct_id":147,"title":148,"phases":149,"status":13,"updated_at":150,"content_modified":151},"NCT07358546","A Study of Efimosfermin Alfa in Adults With Hepatic Impairment",[27],"2026-08-26T02:16:54.876240Z","2026-07-05T05:32:16.678763Z",{"nct_id":153,"title":154,"phases":155,"status":13,"updated_at":156,"content_modified":157},"NCT05165706","Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance",[],"2026-08-26T02:18:17.950264Z","2026-05-05T02:43:26.756994Z",{"nct_id":159,"title":160,"phases":161,"status":13,"updated_at":131,"content_modified":162},"NCT04365855","The Olmsted NAFLD Epidemiology Study (TONES)",[],"2026-05-05T02:43:28.349159Z",{"nct_id":164,"title":165,"phases":166,"status":13,"updated_at":167,"content_modified":168},"NCT04054310","Non-Invasive Quantification of Liver Health in NASH (N-QUAN)",[],"2026-08-26T02:19:01.741747Z","2026-04-29T02:57:57.166228Z",{"nct_id":170,"title":171,"phases":172,"status":13,"updated_at":173,"content_modified":174},"NCT07541469","Rezdiffra Pregnancy and Lactation Registry",[],"2026-08-26T02:18:59.761994Z","2026-05-13T02:55:06.719766Z",{"nct_id":176,"title":177,"phases":178,"status":13,"updated_at":179,"content_modified":180},"NCT07321925","Thermoacoustic Method for Estimating Liver Fat Fraction",[],"2026-08-26T02:16:06.684983Z","2026-05-13T02:55:06.687654Z",{"nct_id":182,"title":183,"phases":184,"status":13,"updated_at":185,"content_modified":186},"NCT05720663","Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis",[],"2026-08-26T02:15:50.539717Z","2026-05-13T02:55:06.372753Z",{"nct_id":188,"title":189,"phases":190,"status":13,"updated_at":191,"content_modified":192},"NCT04232566","Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity",[],"2026-08-26T02:18:46.137046Z","2026-05-13T02:55:06.244207Z",{"nct_id":194,"title":195,"phases":196,"status":13,"updated_at":197,"content_modified":198},"NCT07122700","Evaluation of Non-Invasive Tests for Metabolic Liver Disease",[],"2026-08-26T02:15:09.079045Z","2026-05-13T02:55:06.656773Z",{"nct_id":200,"title":201,"phases":202,"status":13,"updated_at":203,"content_modified":204},"NCT07060547","Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease",[],"2026-08-26T02:15:21.365312Z","2026-05-13T02:55:06.649826Z",{"nct_id":206,"title":207,"phases":208,"status":13,"updated_at":167,"content_modified":209},"NCT06592820","Endoscopic Ultrasound Shear Wave Elastography Study",[],"2026-05-13T02:55:06.552998Z",{"nct_id":211,"title":212,"phases":213,"status":13,"updated_at":214,"content_modified":215},"NCT06124261","Androgens and NAFLD Longitudinal Cohort Study",[],"2026-08-26T02:15:51.395565Z","2026-05-13T02:55:06.416984Z",{"nct_id":217,"title":218,"phases":219,"status":13,"updated_at":220,"content_modified":221},"NCT05728697","Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease",[],"2026-08-26T02:16:16.169331Z","2026-05-13T02:55:06.372763Z",{"nct_id":223,"title":224,"phases":225,"status":13,"updated_at":144,"content_modified":226},"NCT07083557","Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)",[],"2026-05-13T02:55:06.654220Z",{"nct_id":228,"title":229,"phases":230,"status":13,"updated_at":231,"content_modified":232},"NCT03224949","Comparison of ALD, NASH, and Healthy Control Patients",[],"2026-08-26T02:19:24.527214Z","2026-05-13T02:55:06.121030Z",{"nct_id":234,"title":235,"phases":236,"status":13,"updated_at":237,"content_modified":238},"NCT03025074","Blood Collection Biorepository for Liver Disease Research",[],"2026-08-26T02:16:46.951087Z","2026-05-13T02:55:06.105869Z",{"nct_id":240,"title":241,"phases":242,"status":13,"updated_at":243,"content_modified":244},"NCT03884075","Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)",[12],"2026-08-26T02:15:57.572488Z","2026-05-05T02:43:27.249997Z",{"nct_id":246,"title":247,"phases":248,"status":13,"updated_at":249,"content_modified":250},"NCT05979389","Bicalutamide Therapy in Young Women With NAFLD and PCOS",[27],"2026-08-26T02:16:02.918558Z","2026-05-05T02:43:26.850755Z",{"nct_id":252,"title":253,"phases":254,"status":13,"updated_at":255,"content_modified":256},"NCT06824974","Time-restricted Eating and Healthy Eating in Patients With Metabolic Liver Disease or Cancer",[],"2026-08-26T02:16:20.336282Z","2026-07-05T05:32:16.696638Z",{"nct_id":258,"title":259,"phases":260,"status":261,"updated_at":262,"content_modified":263},"NCT07680478","Nutrition Intervention Combined With Resmetirom for MASH",[143],"NOT_YET_RECRUITING","2026-08-26T02:15:33.331531Z","2026-07-05T03:45:20.442632Z",{"nct_id":265,"title":266,"phases":267,"status":261,"updated_at":268,"content_modified":269},"NCT02933554","Bariatric Embolization of Arteries for the Treatment of Nonalcoholic Steatohepatitis",[],"2026-08-26T02:17:34.833510Z","2026-05-05T02:43:27.597155Z",{"nct_id":271,"title":272,"phases":273,"status":261,"updated_at":274,"content_modified":275},"NCT07265843","Fibrinogen in Liver Transplant",[143],"2026-08-26T02:18:58.141497Z","2026-05-05T02:43:28.878100Z",{"nct_id":277,"title":278,"phases":279,"status":261,"updated_at":125,"content_modified":280},"NCT07730853","Isocaloric Navy-Bean Substitution in Adults With MASLD",[],"2026-07-30T01:46:14.452686Z",{"nct_id":282,"title":283,"phases":284,"status":261,"updated_at":285,"content_modified":286},"NCT07732400","A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH)",[70],"2026-08-26T02:15:01.639696Z","2026-07-30T01:46:14.453148Z",{"nct_id":288,"title":289,"phases":290,"status":291,"updated_at":292,"content_modified":293},"NCT06986447","Assessment of Non-Invasive Testing in Major Liver-Related Outcomes",[],"ENROLLING_BY_INVITATION","2026-08-26T02:19:31.671303Z","2026-06-16T05:54:07.850274Z",{"nct_id":295,"title":296,"phases":297,"status":291,"updated_at":298,"content_modified":299},"NCT06703450","Guerbet Liver Fibrosis",[],"2026-08-26T02:17:48.768272Z","2026-06-16T05:54:07.766773Z",{"nct_id":301,"title":302,"phases":303,"status":291,"updated_at":304,"content_modified":305},"NCT00983463","Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)",[],"2026-08-26T02:16:10.529598Z","2026-06-16T05:54:07.944278Z",{"nct_id":307,"title":308,"phases":309,"status":291,"updated_at":310,"content_modified":311},"NCT03407833","Physiologic and Functional Adaptations of Insulin Sensitive Tissues",[],"2026-08-26T02:17:25.718160Z","2026-06-16T05:54:07.968296Z",[],[314,318,322,326,330,334,337,340,344,348,352,355,359,362,366,369,373,376,379,382,385,388,391,395],{"state":315,"count":316,"slug":317},"California",20,"california",{"state":319,"count":320,"slug":321},"Texas",17,"texas",{"state":323,"count":324,"slug":325},"Missouri",16,"missouri",{"state":327,"count":328,"slug":329},"Arizona",15,"arizona",{"state":331,"count":332,"slug":333},"Florida",14,"florida",{"state":335,"count":332,"slug":336},"New York","new-york",{"state":338,"count":332,"slug":339},"Ohio","ohio",{"state":341,"count":342,"slug":343},"Virginia",12,"virginia",{"state":345,"count":346,"slug":347},"Louisiana",11,"louisiana",{"state":349,"count":350,"slug":351},"North Carolina",10,"north-carolina",{"state":353,"count":350,"slug":354},"Tennessee","tennessee",{"state":356,"count":357,"slug":358},"Maryland",9,"maryland",{"state":360,"count":357,"slug":361},"Minnesota","minnesota",{"state":363,"count":364,"slug":365},"Indiana",8,"indiana",{"state":367,"count":364,"slug":368},"Massachusetts","massachusetts",{"state":370,"count":371,"slug":372},"Arkansas",7,"arkansas",{"state":374,"count":371,"slug":375},"Colorado","colorado",{"state":377,"count":371,"slug":378},"Georgia","georgia",{"state":380,"count":371,"slug":381},"Illinois","illinois",{"state":383,"count":371,"slug":384},"Nevada","nevada",{"state":386,"count":371,"slug":387},"Pennsylvania","pennsylvania",{"state":389,"count":371,"slug":390},"Utah","utah",{"state":392,"count":393,"slug":394},"Kansas",6,"kansas",{"state":396,"count":393,"slug":397},"Michigan","michigan"]